Tango Therapeutics, Inc. (TNGX)
20.88
+1.40
(+7.19%)
USD |
NASDAQ |
Mar 25, 16:00
20.61
-0.27
(-1.29%)
Pre-Market: 09:21
Tango Therapeutics Free Cash Flow : -139.93M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revolution Medicines, Inc. | -913.73M |
| Kodiak Sciences, Inc. | -127.29M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
| AbbVie, Inc. | 17.82B |
| Teleflex, Inc. | 245.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.72M |
| Cash from Investing (Quarterly) | -135.72M |
| Cash from Financing (Quarterly) | 219.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2275 |
| Free Cash Flow to Equity (Quarterly) | -28.75M |
| Free Cash Flow to Firm (Quarterly) | -29.94M |
| Free Cash Flow Yield | -5.78% |